Polyxeni T. Mantani

Circulating CD40+ and CD86+ B Cell Subsets Demonstrate Opposing Associations With Risk of Stroke

B. Hedblad, H. Björkbacka, J. Nilsson, 2014, Arteriosclerosis, thrombosis, and vascular biology.

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

M. Lebens, J. Holmgren, H. Björkbacka, 2018, Vascular pharmacology.

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2019, BMC Immunology.

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2015, PloS one.

Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells.

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2018, Human immunology.

Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice

H. Björkbacka, J. Nilsson, I. Ljungcrantz, 2018, The Journal of Biological Chemistry.

IL-25 and B cells in atherosclerosis

Polyxeni T. Mantani, 2014 .